133 related articles for article (PubMed ID: 16963094)
1. Phospholipase B activity and organophosphorus compound toxicity in cultured neural cells.
Read DJ; Langford L; Barbour HR; Forshaw PJ; Glynn P
Toxicol Appl Pharmacol; 2007 Mar; 219(2-3):190-5. PubMed ID: 16963094
[TBL] [Abstract][Full Text] [Related]
2. Effects of organophosphorus compounds on ATP production and mitochondrial integrity in cultured cells.
Massicotte C; Knight K; Van der Schyf CJ; Jortner BS; Ehrich M
Neurotox Res; 2005; 7(3):203-17. PubMed ID: 15897155
[TBL] [Abstract][Full Text] [Related]
3. Acetylcholinesterase and neuropathy target esterase inhibitions in neuroblastoma cells to distinguish organophosphorus compounds causing acute and delayed neurotoxicity.
Ehrich M; Correll L; Veronesi B
Fundam Appl Toxicol; 1997 Jul; 38(1):55-63. PubMed ID: 9268605
[TBL] [Abstract][Full Text] [Related]
4. The alteration of the expression level of neuropathy target esterase in human neuroblastoma SK-N-SH cells disrupts cellular phospholipids homeostasis.
Hou WY; Song X; Wang Y; Chang P; Chen R; Wu YJ
Toxicol In Vitro; 2023 Feb; 86():105509. PubMed ID: 36336212
[TBL] [Abstract][Full Text] [Related]
5. Morphological effects of neuropathy-inducing organophosphorus compounds in primary dorsal root ganglia cell cultures.
Massicotte C; Jortner BS; Ehrich M
Neurotoxicology; 2003 Dec; 24(6):787-96. PubMed ID: 14637373
[TBL] [Abstract][Full Text] [Related]
6. Neuropathy target esterase in mouse whole blood as a biomarker of exposure to neuropathic organophosphorus compounds.
Makhaeva GF; Rudakova EV; Sigolaeva LV; Kurochkin IN; Richardson RJ
J Appl Toxicol; 2016 Nov; 36(11):1468-75. PubMed ID: 26970094
[TBL] [Abstract][Full Text] [Related]
7. In vitro study of the neuropathic potential of the organophosphorus compounds fenamiphos and profenofos: Comparison with mipafox and paraoxon.
Emerick GL; Fernandes LS; de Paula ES; Barbosa F; dos Santos NA; dos Santos AC
Toxicol In Vitro; 2015 Aug; 29(5):1079-87. PubMed ID: 25910916
[TBL] [Abstract][Full Text] [Related]
8. NTE soluble isoforms: new perspectives for targets of neuropathy inducers and promoters.
Vilanova E; Escudero MA; Barril J
Chem Biol Interact; 1999 May; 119-120():525-40. PubMed ID: 10421492
[TBL] [Abstract][Full Text] [Related]
9. The homeostasis of phosphatidylcholine and lysophosphatidylcholine in nervous tissues of mice was not disrupted after administration of tri-o-cresyl phosphate.
Hou WY; Long DX; Wu YJ
Toxicol Sci; 2009 Jun; 109(2):276-85. PubMed ID: 19349639
[TBL] [Abstract][Full Text] [Related]
10. Potentiation of organophosphorus-induced delayed neurotoxicity following phenyl saligenin phosphate exposures in 2-, 5-, and 8-week-old chickens.
Harp P; Tanaka D; Pope CN
Fundam Appl Toxicol; 1997 May; 37(1):64-70. PubMed ID: 9193923
[TBL] [Abstract][Full Text] [Related]
11. Assessment of neurotoxic effects of tri-cresyl phosphates (TCPs) and cresyl saligenin phosphate (CBDP) using a combination of in vitro techniques.
Hausherr V; Schöbel N; Liebing J; van Thriel C
Neurotoxicology; 2017 Mar; 59():210-221. PubMed ID: 27288108
[TBL] [Abstract][Full Text] [Related]
12. Avian embryonic brain reaggregate culture system. II. NTE activity discriminates between effects of a single neuropathic or nonneuropathic organophosphorus compound exposure.
Funk KA; Liu CH; Higgins RJ; Wilson BW
Toxicol Appl Pharmacol; 1994 Jan; 124(1):159-63. PubMed ID: 8291056
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of carboxylesterases in SH-SY5Y human and NB41A3 mouse neuroblastoma cells by organophosphorus esters.
Ehrich M; Correll L
J Toxicol Environ Health A; 1998 Mar; 53(5):385-99. PubMed ID: 9515941
[TBL] [Abstract][Full Text] [Related]
14. The homeostasis of phosphatidylcholine and lysophosphatidylcholine was not disrupted during tri-o-cresyl phosphate-induced delayed neurotoxicity in hens.
Hou WY; Long DX; Wang HP; Wang Q; Wu YJ
Toxicology; 2008 Oct; 252(1-3):56-63. PubMed ID: 18755237
[TBL] [Abstract][Full Text] [Related]
15. Discrimination of carboxylesterases of chicken neural tissue by inhibition with a neuropathic, non-neuropathic organophosphorus compounds and neuropathy promoter.
Céspedes MV; Escudero MA; Barril J; Sogorb MA; Vicedo JL; Vilanova E
Chem Biol Interact; 1997 Oct; 106(3):191-200. PubMed ID: 9413546
[TBL] [Abstract][Full Text] [Related]
16. Degradation of organophosphorus neurotoxicity in SY5Y neuroblastoma cells by organophosphorus hydrolase (OPH).
Cho TM; Wild JR; Donnelly KC; Tiffany-Castiglioni E
J Toxicol Environ Health A; 2006 Aug; 69(15):1413-29. PubMed ID: 16766477
[TBL] [Abstract][Full Text] [Related]
17. Effect of cyclic phenyl saligenin phosphate and paraoxon treatment on vascular response to adrenergic and cholinergic agents in hens.
McCain WC; Wilcke J; Lee JC; Ehrich M
J Toxicol Environ Health; 1995 Feb; 44(2):167-87. PubMed ID: 7853421
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the relative inhibition of acetylcholinesterase and neuropathy target esterase in rats and hens given cholinesterase inhibitors.
Ehrich M; Jortner BS; Padilla S
Fundam Appl Toxicol; 1995 Jan; 24(1):94-101. PubMed ID: 7713347
[TBL] [Abstract][Full Text] [Related]
19. Organophosphorus compound-induced apoptosis in SH-SY5Y human neuroblastoma cells.
Carlson K; Jortner BS; Ehrich M
Toxicol Appl Pharmacol; 2000 Oct; 168(2):102-13. PubMed ID: 11032765
[TBL] [Abstract][Full Text] [Related]
20. Genomic and phenotypic alterations of the neuronal-like cells derived from human embryonal carcinoma stem cells (NT2) caused by exposure to organophosphorus compounds paraoxon and mipafox.
Pamies D; Sogorb MA; Fabbri M; Gribaldo L; Collotta A; Scelfo B; Vilanova E; Harris G; Bal-Price A
Int J Mol Sci; 2014 Jan; 15(1):905-26. PubMed ID: 24413757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
